Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02957136 · ClinicalTrials.gov registry record · NA
Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT02957136: Completed NA study, sponsored by University of California, Davis.
NCT02957136 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02957136, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
This is a randomized clinical trial to assess the effect of rapid, near point-of-care testing for multiple common respiratory viruses and bacteria on antibiotic and anti-influenza medication use in emergency department (ED) patients with symptoms of influenza-like illness (ILI) and/or upper respiratory infection (URI).
Interventions
- DEVICE Rapid respiratory pathogen nucleic acid amplification test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2016-12-08 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
What the finished NCT02957136 record still lists
NCT02957136 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Rapid respiratory pathogen nucleic acid amplification test is the first listed.
NCT02957136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02957136 about?
NCT02957136 is a clinical study titled "Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department". This is a randomized clinical trial to assess the effect of rapid, near point-of-care testing for multiple common respiratory viruses and bacteria on antibiotic and anti-influenza medication use in emergency department (ED) patients with symptoms of influenza-like illness (ILI) and/or upper respirat...
What is the current status of trial NCT02957136?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2016-12-08. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT02957136?
The interventions under investigation include: Rapid respiratory pathogen nucleic acid amplification test (DEVICE).
Who is sponsoring clinical trial NCT02957136?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02957136's enrollment target sits among peer trials
194 568th of 2000 higher than 1,432 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI